Skip to Content
You are currently on the new version of our website. Access the old version .
  • Article
  • Open Access

14 April 2003

18 Pages

Synthesis and in vitro Anti-HIV Screening of Certain 2-(Benzoxazol-2-ylamino)-3H-4-oxopyrimidines

,
and
1
Division of Medicinal Chemistry, Faculty of Medicine and Allied Sciences, King Abdul-Aziz University, P.O. Box 80205, Jeddah 2 1589, Kingdom Saudi Arabia
2
School of Pharmacy, University of Mississippi, Mississippi 38677, USA
3
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, 2 12 15 Alexandria, A. R. Egypt
*
Author to whom correspondence should be addressed.

Abstract

Intensive efforts are underway worldwide to develop chemotherapeutic agents effective against HIV, the etiological agent of AIDS. In this view, it was designed to synthesize and investigate the anti-HIV activity of some new 2-(benzoxazol-2-ylamino)-3H-4-oxopyrimidines following the lead benzoxazole (L 697, 661), which was reported to inhibit the spread of the HIV infection by 95 % in MT4 cell culture. Only the 2-(benzoxazol-2-ylarnino)-6-hydroxy-3H-4-oxopyrdine 8 (NSC 722448) was confirmed to exhibit moderate in vitro anti-HIV activity (percentage of protection 76.83 %).

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.